Physician profile
Benjamin Kunesh
NPI 1477524148
$486.65
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $87.52 · 2023: $339 · 2024: $59.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $131.14 | 2022-2023 | Freestyle Libre 3 |
| Pfizer INC. | $69.19 | 2023-2024 | |
| Exact Sciences Corporation | $55.31 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $37.29 | 2023 | Mounjaro |
| Horizon Therapeutics Plc | $31.01 | 2023 | Krystexxa |
| Sumitomo Pharma America, INC. | $26.36 | 2023 | Gemtesa |
| Medtronic, INC. | $24.05 | 2023 | Intellis Adaptivestim |
| Novartis Pharmaceuticals Corporation | $20.99 | 2023 | |
| Novo Nordisk INC | $20.36 | 2024 | Wegovy |
| Janssen Pharmaceuticals, INC | $20.05 | 2022 | |
| Phathom Pharmaceuticals, INC. | $19.61 | 2024 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $16.60 | 2023 | Farxiga |
| Shield Therapeutics INC | $14.69 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Kunesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.